Legal 500
  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • Article

    Nanotechnology In The Pandemic And What The Future Holds For Regulation

    Every day, nanotechnology, the miniaturization of particles in the industrial and manufacturing process down to a billionth of a meter in size, ...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    New FDA Tip Sheet

    This is a great update regarding new FDA regulations concerning the supply of critical foods including infant formula and medical foods.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Personalized Multiplex Test On Market

    A multiplex test that can analyze tumors for over 200 genes is now available from Foundation Medicine Inc., the Wall Street Journal reported today.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Privacy Issues In The Sharing Of Genetic Information 1 Oct 2014

    Low cost sequencing of a patient’s genome and advances in the interpretation of a patient’s genetic information is promised to transform the delivery of health care.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Protecting Bees: The Buzz About A New Vaccine

    Bees and insects face diseases similar to humans, and American foulbrood poses a significant threat to bee colonies.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Repositioning Of Nursing Homes To Alternative Models Of Care

    Whatever the future, it is reasonably likely that regulators will more carefully watch closure and repositioning projects to ensure access to SNF beds...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Safer And More Powerful Batteries – Dreamliner And Political

    The Wall Street Journal and other media are reporting that the National Transportation Safety Board is investigating microscopic "dendrite" formation as possible causes for the "dreamliner" lithium ion battery problems.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Sunny Levine Discusses Future Of Telemedicine On Podnosis Podcast

    Foley & Lardner LLP Senior Counsel Sunny Levine is interviewed on the latest episode of Podnosis, Fierce Healthcare's weekly podcast covering the biggest trends in health care, discussing...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Supreme Court Decides Myriad Case: Synthetic DNA Held Patentable & Implications For Nanotech

    The Supreme Court recently rendered its decision in the landmark Myriad case, holding that naturally occurring DNA segments are not patentable, but synthetic DNA segments are patent eligible based on the patent eligibility requirement of 35 U.S.C.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    The Future Of Reproductive Health: Building & Investing In Post-Roe America

    Claire Marblestone, will be a speaker at The Future of Reproductive Health: Building & Investing in Post-Roe America.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Updates With Materials Genome Initiative, $25M Grants Announced; Complex IP Issues?

    The Office of Science and Technology Policy (OSTP) recently announced updates with the Materials Genonme Initiative (MGI). $25M in grants are noted, and the awardees include universities, national laboratories, and private sector companies (e.g., GM). Collaboration continues to be a strong theme.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    U.S. Patent Office Issues Guidance To Examiners On Supreme Court's Myriad Decision

    The USPTO recently issued guidance to Examiners on how to apply the Myriad Supreme Court decision to applications under examination.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    USC Announces Stem Cell Collaboration

    Treatment and prevention of heart failure are unmet medical needs in the United States. One in every eight deaths in the United States can be linked to this disease.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    USPTO Imposes New Limits On Credit Card Payments

    As announced on the USPTO website, as of June 30, 2012, there will be a daily limit of $49,999.99 for credit card accounts, but no daily limit for debit card accounts.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    We Look Forward To Seeing You At The Telehealth And The 2023 Medicare Physician Fee Webinar

    We hope that you can join Foley Partners, Nathaniel Lacktman and T.J. Ferrante, at the Health Tech Nerds (HTN) member webinar on August 11, 2022.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    What The Department Of Justice's 2025 FCA Recoveries Signal For 2026: Health Care, Cyber, And Customs

    The DOJ and relators' bar continues to aggressively deploy the False Claims Act across a variety of subject areas, including health care, cybersecurity, and customs.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Video

    Midterm Elections: What Happens Now? (Video)

    During this presentation, Jason Kohout, co-chair of Foley's Family Office practice, and Scott Klug, public affairs director and co-chair of the Federal Public Affairs practice...
    United StatesGovernment, Public Sector
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Vanessa Miller Discusses Solutions To The Demand For Semiconductors

    Foley & Lardner LLP Partner Vanessa Miller was featured in the article, "Buyer Beware: Avoid These 3 Semiconductor Procurement Pitfalls," in Supply Chain Dive...
    United StatesGovernment, Public Sector
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Good News For Patentees: Five Years After KSR, New Case Reveals "Poster Child For Impermissable Hindsight Reasoning"

    The KSR Supreme Court decision on obviousness is now more that five years old (decision rendered April 30, 2007).
    United StatesIntellectual Property
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Guarding Against Conclusory Statements & Why It Matters Even More Under The New PTAB Rules

    A good practice is to have a fresh pair of eyes go through each sentence of the expert's declaration before filing and ask the question – is there support or evidence that can be added to back up that statement?
    United StatesIntellectual Property
    Foley & Lardner LLP
    Foley & Lardner LLP

Showing 241–260 of 10838 results

PreviousNext
Legal Intelligence Newsletters